Connect
MJA
MJA

Diabetes management — keeping up to date

Lynn M Weekes
Med J Aust 2016; 205 (7): 288. || doi: 10.5694/mja16.00829
Published online: 3 October 2016

The management of type 2 diabetes (T2D) is rapidly evolving with the introduction of an increasing number of new medicines, updating of guidelines and emerging clinical outcome data. Medicine selection for treatment of T2D has become increasingly complex — especially when considering the Pharmaceutical Benefits Scheme subsidy of certain medicine combinations. On the other hand, some things have not changed; optimising glycaemic control, managing risk of complications and promoting a healthy lifestyle are still the cornerstones of diabetes care. Despite the new medicines available for the treatment of T2D, prescribers should continue to individualise their choice of therapy at each point of escalation based on patient and medicine factors.

  • Lynn M Weekes

  • NPS MedicineWise, Sydney, NSW

Correspondence: lweekes@nps.org.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.